For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration ...
The FDA’s new Commissioner’s National Priority Voucher signals a transformative shift in U.S. drug review, tying accelerated approval to manufacturing readiness, domestic supply-chain strength, and ...
US FDA approves Henlius and Organon’s Poherdy, the first Perjeta biosimilar: Shanghai Tuesday, November 18, 2025, 16:00 Hrs [IST] Shanghai Henlius Biotech, Inc., a global health ...
For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration ...
Pharmaceutical Technology on MSNOpinion
FDA inspection reveals critical supply chain vulnerabilities
Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into ...
In recent months, Morocco has witnessed an unprecedented surge in public debates about food quality and safety. At the heart ...
Researchers said a survey of U.S. adults found 72% say sleepiness sometimes, often or always gets in the way of their ...
Shoppers Drug Mart billed the Ontario government’s MedsCheck program $81.2 million for medication reviews over a two-year ...
Hercules Capital offers high yield, strong credit quality, and growth—making it a top Strong Buy for income investors. Read ...
A cheese brand has recalled one of its products over a serious health risk.
Roughly one-in-four generic drugs taken by Americans rely on key ingredients from China, according to a report ...
(THE CONVERSATION) For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration describing the medication’s risk of serious harms – namely, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback